Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients

J.A. Erkens, O.H. Klungel, R.M.C. Herings, R.P. Stolk, J.A. Spoelstra, D.E. Grobbee, H.G.M. Leufkens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1575-1579
Number of pages5
JournalEuropean Heart Journal
Volume23
Publication statusPublished - 2002

Keywords

  • Farmacie/Biofarmaceutische wetenschappen (FARM)
  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this